Product Program year 2020 Source: CMS Open Payments

Amg334a_Aimovig_Neuroscience

Biological Neuroscience

NDC 55513-841-01

Open in the dashboard

General payments

$64,941

37 payments

Research payments

$27,958

7 payments

Through program year 2020, $64,941 in general payments and $27,958 in research payments were reported against Amg334a_Aimovig_Neuroscience (Neuroscience).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $9,654 6
2020 Research $27,958 7
2019 General $55,287 31

Breakdown

Who paid General payments · program years 2019–2020
  1. Novartis Pharma AG $64,941 37 payments
Top recipients General payments · program year 2020
  1. Richard Lipton Neurology · Bronx, NY $5,806 60% · 4 payments
  2. Merle Diamond Internal Medicine · Chicago, IL $1,988 21% · 1 payment
  3. David Dodick Neurology · New York, NY $1,860 19% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Neurology Psychiatry & Neurology $7,666 79% · 2 practitioners
  2. Internal Medicine $1,988 21% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. New York $5,806 60% · 1 recipient
  2. Illinois $1,988 21% · 1 recipient
  3. Arizona $1,860 19% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

37 general · 7 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record